You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Diabetes - Niclosamide - Diabetic kidney disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetic Nephropathies Trial in Tanta (Niclosamide, Placebo oral tablet)

Completed
  • Diabetic Nephropathies
  • Tanta, Egypt
    Faculty of Pharmacy, Tanta University
Oct 19, 2022

Diabetic Kidney Disease, Type 1 Diabetes Trial (Semaglutide, Placebo)

Not yet recruiting
  • Diabetic Kidney Disease
  • Type 1 Diabetes
  • (no location specified)
Apr 18, 2023

Prevent Diabetic Kidney Disease Among Egyptians

Not yet recruiting
  • Diabetes Mellitus Without Complication
  • (no location specified)
Oct 6, 2023

Nephropathy, Diabetic Nephropathies, Diabetes, Type 1 Trial in Herlev (Sotagliflozin, Placebo)

Not yet recruiting
  • Nephropathy
  • +6 more
  • Herlev, Denmark
    Steno Diabetes Center Copenhagen
Nov 19, 2023

Diabetic Kidney Disease, Diabetes Type 2, Chronic Kidney Diseases Trial

Not yet recruiting
  • Diabetic Kidney Disease
  • +3 more
    • (no location specified)
    Nov 23, 2022

    Chronic Kidney Disease Among Type 2 Diabetic Assiut University

    Recruiting
    • Type 2 Diabetes With Renal Manifestations
      • Assiut, Egypt
        Assiut
      May 5, 2023

      Type2diabetes, Diabetic Kidney Disease Trial (Investigational Product - MIB 626, Placebo)

      Not yet recruiting
      • Type2diabetes
      • Diabetic Kidney Disease
      • Investigational Product - MIB 626
      • Placebo
      • (no location specified)
      Mar 6, 2023

      Type2Diabetes, ASCVD Trial (SGLT2 inhibitor, GLP-1 receptor agonist, Combination drug)

      Recruiting
      • Type2Diabetes
      • ASCVD
      • SGLT2 inhibitor
      • +2 more
      • New York, New York
      • +1 more
      Dec 19, 2022

      Diabetic Kidney Disease Trial (Soleus ms exercise)

      Not yet recruiting
      • Diabetic Kidney Disease
      • Soleus ms exercise
      • (no location specified)
      Nov 4, 2023

      Revealing Engagement Dynamics Among Diabetic Kidney Disease

      Not yet recruiting
      • Diabetic Kidney Disease
        • San Francisco, California
          Power Life Sciences
        Oct 20, 2023

        Multidimensional Adversity in Inner-City African American

        Not yet recruiting
        • Diabetic Nephropathy Type 2 - Uncontrolled
        • +2 more
        • Patient and Community Stakeholder Interviews
        • +2 more
        • Milwaukee, Wisconsin
          Medical College of Wisconsin
        Jan 11, 2023

        Thickening of Bowman's Capsule on Clinical Prognosis of Diabetic

        Not yet recruiting
        • Diabetic Kidney Disease
        • Extracellular Matrix Alteration
        • no intervention
        • (no location specified)
        Sep 15, 2023

        Kidney Disease in Type 1 Diabetes:Modern Kidney Biopsy Cohort

        Not yet recruiting
        • Type 1 Diabetes
        • +4 more
        • Aminohippurate Sodium Inj 20% Diagnostic aid/agent used to measure effective renal plasma flow (ERPF)
        • Iohexol Inj 300 MG/ML Diagnostic aid/agent used to measure glomerular filtration rate (GFR)
        • Aurora, Colorado
          Children's Hospital Colorado
        Sep 8, 2022

        Chronic Kidney Diseases, Diabetes, Diabetic Nephropathies Trial in Rochester (Fisetin, Placebo oral capsule)

        Enrolling by invitation
        • Chronic Kidney Diseases
        • +2 more
        • Fisetin
        • Placebo oral capsule
        • Rochester, Minnesota
          Mayo Clinic in Rochester
        Nov 9, 2022

        Diagnostic Value of Serum Cathepsin S and Chromogranin A in DKD

        Not yet recruiting
        • Diabetic Kidney Disease
        • cathepsin S and chromogranin A
        • (no location specified)
        Oct 5, 2023

        Proteinuria, Kidney Dysfunction, Blood Pressure Trial in Hanzhou (Azilsartan, Losartan)

        Recruiting
        • Proteinuria
        • +3 more
        • Hanzhou, Zhejiang, China
          the Second Afficiated Hospital, Zhejiang University, School of M
        Feb 22, 2023

        Kidney Alone Versus Islet-After-Kidney in Type 1 Diabetic Kidney

        Recruiting
        • type1diabetes
        • +2 more
        • Pancreatic islet transplantation after kidney transplantation
        • Lille, France
          Hop Claude Huriez Chu Lille
        Dec 21, 2022

        T2DM (Type 2 Diabetes), Metformin, SGLT2-Inhibitors Trial in Matsumoto (Tofogliflozin, Metformin)

        Recruiting
        • T2DM (Type 2 Diabetes Mellitus)
        • +2 more
        • Matsumoto, Nagano, Japan
          Shinshu University
        Jul 21, 2022

        End-stage Kidney Disease, Kidney Disease, Chronic, Dialysis Trial (Empagliflozin, Placebo)

        Not yet recruiting
        • End-stage Kidney Disease
        • +7 more
        • (no location specified)
        Jan 9, 2023

        Technology and Clinical Transformation of Type 2 Diabetes

        Recruiting
        • Diabetic Nephropathy Type 2
        • +2 more
          • Beijing, China
            Chinese PLA General Hospital
          May 25, 2023

          Diabetes, Magnetic Resonance Imaging Trial in Beijing (Polysaccharide superparamagnetic iron oxide injection)

          Completed
          • Diabetes
          • Magnetic Resonance Imaging
          • Polysaccharide superparamagnetic iron oxide injection
          • Beijing, Beijing, China
            Beijing Luhe Hospital, Capital Medical University
          Sep 27, 2023

          Type 2 Diabetes, Diabetic Kidney Disease Trial in Aurora, Boston, Ann Arbor (canagliflozin, Aminohippurate Sodium Inj 20%)

          Recruiting
          • Type 2 Diabetes
          • Diabetic Kidney Disease
          • Aurora, Colorado
          • +3 more
          Aug 17, 2022

          Diabetes, Type 2 Diabetes, Type 1 Diabetes Trial in Shatin

          Recruiting
          • Diabetes Mellitus
          • +10 more
            • Shatin, Hong Kong
              Prince of Wales Hospital
            Mar 7, 2022

            Chronic Kidney Diseases Trial (Empagliflozin 10 MG, Placebo)

            Not yet recruiting
            • Chronic Kidney Diseases
            • Empagliflozin 10 MG
            • Placebo
            • (no location specified)
            Oct 30, 2023

            Chronic Kidney Disease (CKD) With Diabetes (DM), CKD Stage 3, CKD Stage 4 Trial (PLAFOND diet)

            Not yet recruiting
            • Chronic Kidney Disease (CKD) With Diabetes Mellitus (DM)
            • +5 more
            • PLAFOND diet
            • (no location specified)
            Aug 21, 2022